ARCHIVES

DCT board Okays Recompetition of Clinical Trials Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 42 | October 29, 1993

Download PDF Visit The Full Archive

Related Articles

Bypass Budget Is Realistic, Defensible Plan, Broder Says

September 27, 1991

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

October 6, 1989

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

GAO Calls For Stronger FDA Enforcement Of Accelerated Approval Followup Studies

October 30, 2009

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

July 28, 2006